• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PFLT

PFLT

PennantPark Floating Rate Capital Ltd.

NYSEFinancial ServicesAsset ManagementUS

USD8.05

-0.29 (-3.48%)

Rating:C+

Company Profile

CEO

Arthur Howard Penn

IPO Date

2011-04-08

Sector

Financial Services

Industry

Asset Management

Exchange

NYSE

Country

US

Market Metrics

Open

$8.25

Prev. Close

$8.34

Day Low

$8.03

Day High

$8.26

52W Low

$7.68

52W High

$10.88

Market Cap

$0.80B

Volume

1.51M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

12.8%

Avg Negative

4.0%

Avg Neutral

83.4%

News Feed

PennantPark Floating Rate: This Overlooked Gem Is A Buy, Here's Why

Seeking Alpha·7/29/2021·↑ positive

PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of Third Fiscal Quarter 2021 Results

GlobeNewsWire·7/1/2021·↓ negative

PennantPark Floating Rate Capital Ltd. Appoints Richard Cheung as New Chief Financial Officer

GlobeNewsWire·
6/21/2021
·↑ positive

PennantPark Floating Rate Capital Ltd. Announces Financial Results for the Quarter Ended March 31, 2021

GlobeNewsWire·5/5/2021·↓ negative

PennantPark Floating Rate Capital: Don't Count Your Chickens Before They Hatch

Seeking Alpha·5/3/2021·↓ negative

PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of Second Fiscal Quarter 2021 Results

GlobeNewsWire·4/8/2021·↓ negative

PennantPark Floating Rate Capital Ltd. Prices Public Offering of $100.0 Million 4.25% Unsecured Notes Due 2026

GlobeNewsWire·3/19/2021·↑ positive

Why 9.7%-Yielding PennantPark Floating Rate Capital Remains A Buy

Seeking Alpha·2/18/2021·↑ positive

PennantPark Floating Rate Capital (PFLT) CEO Art Penn on Q1 2021Results - Earnings Call Transcript

Seeking Alpha·2/10/2021·↓ negative

PennantPark (PFLT) Lags Q1 Earnings and Revenue Estimates

Zacks Investment Research·2/9/2021·↑ positive